Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Clinical trial NCT00070252 · COMPLETED

Trial details

NCT number: NCT00070252
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adult Solid Neoplasm Inflammatory Breast Carcinoma Male Breast Carcinoma Stage IIIA Breast Cancer Stage IIIB Breast Cancer

Start date: 2003-09-01
Primary completion: 2006-02-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.